Eloxx Pharmaceuticals Inc
ELOX
Market Cap$314
Close$
$2.69
2687900% upside
Current Fair Value
2687900% upsideUndervalued by 2687900% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $314.00 |
|---|---|
| Enterprise Value | $13.95 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-16.65 |
| Beta | -24.6 |
| Outstanding Shares | 2,747,687 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.73 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.34 |
| Debt to Equity | -0.93 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Eloxx Pharmaceuticals Inc
CEO: Robert Ward